Lonza hikes API production capacity
Switzerland's Lonza has boosted its ability to make active pharmaceutical ingredients (API) at its Visp site in response to what it said was 'ever increasing hygienic and regulatory requirements'.
Archives for September 12, 2005
SuperArray launches PCR-based microarray
SuperArray Bioscience has introduced a product that combines the profiling capabilities of microarrays with the performance of real-time PCR. This novel technology will bring expression profiling to researchers who prefer PCR based methods to...
Viral treatment opens lab research avenues.
Researchers have discovered a single therapy that could treat four viral diseases, which could mean new avenues of laboratory research. The treatment focuses on viruses responsible for HIV, measles, Ebola and Marburg.
DynaPro used in protein freezing studies
Wyatt Technology's DynaPro Titan range of dynamic light scattering (DLS) instruments can be used to determine whether freezing alters a protein's homogeneity, according to researchers in France.
Lollipop painkiller goes sugar free
Sugar is a useful excipient for use in medications because of its ability to mask bitter tastes, but its use in drugs intended for chronic use, or which reside in the mouth for an extended period, raises the risk of dental caries.
Ambion and Rosetta in microRNA deal
Ambion and Rosetta Genomics have announced a licensing and commercialisaton agreement to advance microRNA research. The results will facilitate microRNA research that hails this as a promising area in the treatment of a range of diseases.
Biovitrum enters trials for glaucoma drug
Biovitrum has initiated phase I trials for its glaucoma drug candidate that aims to improve over existing current treatments and satisfy the need in the market for new drugs with novel active mechanisms of action.